Index of reports
> Death (44)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Decadron (Dexamethasone) death. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 44 Next >>
Possible Decadron side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Decadron
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Decadron side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Decadron
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Oncaspar
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Decadron side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Decadron
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Decadron side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Decadron
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Oncaspar
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Decadron side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Decadron
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Decadron side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Decadron
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Oncaspar
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Decadron side effects in
Reported by a physician from Korea, Republic of on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Decadron
Dosage: 40 mg, cyclic
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Decadron side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Oncaspar
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Decadron
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Decadron side effects in female
Reported by a physician from Japan on 2012-07-31
Patient: female, weighing 34.5 kg (75.9 pounds)
Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Febrile Neutropenia, Multiple Myeloma, Neutrophil Count Decreased, Hypertension
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-02
End date: 2010-10-22
Decadron
Dosage: 6.6mg x 2
Start date: 2010-10-30
End date: 2010-11-02
Decadron
Dosage: 1.65g x 1
Start date: 2010-10-30
End date: 2010-11-02
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2010-11-27
End date: 2010-12-02
Decadron
Dosage: 6.6mg x 5
Start date: 2010-10-10
End date: 2010-10-13
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-10-30
End date: 2010-11-19
Decadron
Dosage: 6.6mg x 5
Indication: Multiple Myeloma
Start date: 2010-10-02
End date: 2010-10-05
Other drugs received by patient: Omeprazole; Lasix; Fentanyl-100; Lasix; Orgaran; Loxonin; Neophyllin
Possible Decadron side effects in 65 year old
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16
Patient: 65 year old
Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Acidosis, Prothrombin Time Prolonged, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, White Blood Cell Count Decreased, Hypotension, International Normalised Ratio Increased, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Alkeran
Indication: Product Used FOR Unknown Indication
Decadron
Indication: Product Used FOR Unknown Indication
Possible Decadron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10
Patient:
Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Acidosis, Prothrombin Time Prolonged, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Decreased, Blood Alkaline Phosphatase Increased, International Normalised Ratio Increased, Hypotension, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 20 mg, qw
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-31
End date: 2010-08-28
Decadron
Dosage: 12 mg, qd
Administration route: Oral
Start date: 2010-11-12
End date: 2010-11-15
Revlimid
Dosage: 25 mg, qd
Indication: Multiple Myeloma
Start date: 2010-08-15
Other drugs received by patient: Alkeran
Possible Decadron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: female, weighing 95.2 kg (209.4 pounds)
Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Prothrombin Time Prolonged, Acidosis, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Renal Failure Acute, Blood Alkaline Phosphatase Increased, White Blood Cell Count Decreased, International Normalised Ratio Increased, Hypotension, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-31
End date: 2010-08-28
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-08-15
End date: 2010-08-30
Decadron
Dosage: 12 milligram
Administration route: Oral
Start date: 2010-11-12
End date: 2010-11-15
Alkeran
Dosage: 14 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-11-12
End date: 2010-11-15
Possible Decadron side effects in 77 year old male
Reported by a physician from United States on 2012-06-19
Patient: 77 year old male
Reactions: Weight Decreased, White Blood Cell Count Decreased, Pyrexia, Fall, Delirium, Aspergillosis, Platelet Count Decreased, non-Hodgkin's Lymphoma, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Other drugs received by patient: Proscar; Folic Acid; Potassium Chloride; Ferrous Sulfate; Prochlorperazine Maleate; Prochlorperazine Maleate
Possible Decadron side effects in 76 year old male
Reported by a physician from Japan on 2012-06-19
Patient: 76 year old male, weighing 51.0 kg (112.2 pounds)
Reactions: Pulmonary Tuberculosis, Hepatic Neoplasm Malignant, Palmar-Plantar Erythrodysaesthesia Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Nexavar
Dosage: 400 mg, bid
Administration route: Oral
Indication: Hepatic Neoplasm Malignant
Start date: 2009-10-21
End date: 2009-11-01
Decadron
Dosage: daily dose 2 mg
Administration route: Oral
Indication: Neoplasm Malignant
Start date: 2011-06-20
End date: 2011-08-08
Nexavar
Dosage: 400 mg (daily dose), , oral
Administration route: Oral
Start date: 2009-11-09
End date: 2011-08-08
Other drugs received by patient: Mucosolvan; Naproxen; Aspirin; Lansoprazole; Lasix; Levofloxacin; Urso 250; Ticlopidine HCL
Possible Decadron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-13
Patient: female
Reactions: Hypoxic-Ischaemic Encephalopathy, Cardio-Respiratory Arrest, Aspiration, Pneumothorax
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-06-21
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-06-22
Other drugs received by patient: Omeprazole; Procrit; Aspirin; Digoxin; Senna-Mint WAF; Aldactone; Coumadin; Blood Transfusion; Citalopram; Metronidazole
Possible Decadron side effects in 77 year old male
Reported by a physician from United States on 2012-06-08
Patient: 77 year old male
Reactions: Weight Decreased, White Blood Cell Count Decreased, Pyrexia, Fall, Delirium, Aspergillosis, Platelet Count Decreased, non-Hodgkin's Lymphoma, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Other drugs received by patient: Potassium Chloride; Ferrous Sulfate; Proscar; Folic Acid; Prochlorperazine Maleate; Prochlorperazine Maleate
Possible Decadron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Back Pain, Death, Arthralgia, Pain in Extremity, Hypotension, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Dosage: 40 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-11-08
End date: 2010-11-09
Velcade
Dosage: 2 mg, cyclic
Indication: Multiple Myeloma
Start date: 2010-11-08
End date: 2010-11-08
Possible Decadron side effects in 45 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-18
Patient: 45 year old female
Reactions: Skin Chapped, Abdominal Pain, Muscle Atrophy, Headache, Erythema, Malaise, Bronchitis Viral, Ingrowing Nail, Localised Infection, Cushingoid, Pain in Extremity, Bursitis, LIP Ulceration, Myopathy, Breast Cancer Metastatic, Joint Swelling, Rash Maculo-Papular, Metastases To Central Nervous System, Purulent Discharge, Skin Toxicity, Scab, Fatigue, Skin Ulcer, Chest Pain, Dizziness, Abdominal Distension, Oedema, Coordination Abnormal, Gastrooesophageal Reflux Disease, Rash Pustular, Vomiting, Gastrointestinal Toxicity, Muscular Weakness, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, DRY Skin, Diarrhoea, Gait Disturbance
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Lapatinib
Indication: Breast Cancer Metastatic
Start date: 2011-03-04
Decadron
Administration route: Oral
Indication: Metastases To Central Nervous System
Capecitabine
Indication: Breast Cancer Metastatic
Start date: 2011-03-04
Acyclovir
Other drugs received by patient: Herceptin; Zoledronate Disodium
Possible Decadron side effects in female
Reported by a physician from Japan on 2012-05-18
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: Anal Fistula, Oesophageal Candidiasis, Subcutaneous Abscess, Rectal Perforation, Gastric Ulcer, Disease Progression
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Irinotecan Hydrochloride
Start date: 2011-08-11
End date: 2011-09-22
Irinotecan Hydrochloride
Dosage: dosage is uncertain.
Start date: 2011-05-19
End date: 2011-01-01
Lobu
Administration route: Oral
Indication: Cancer Pain
Start date: 2010-11-18
End date: 2011-11-01
Decadron
Dosage: dosage is uncertain.
Indication: Product Used FOR Unknown Indication
Avastin
Start date: 2010-08-05
End date: 2011-01-06
Avastin
Start date: 2011-03-17
End date: 2011-04-28
TS-1
Dosage: it is two administering weekly holiday medicine for two weeks.
Administration route: Oral
Indication: Rectal Cancer Metastatic
Start date: 2011-08-11
End date: 2011-09-21
Irinotecan Hydrochloride
Dosage: dosage is uncertain.
Indication: Rectal Cancer Metastatic
Start date: 2011-04-28
End date: 2011-04-28
Avastin
Start date: 2011-08-11
End date: 2011-09-22
Avastin
Indication: Rectal Cancer Metastatic
Start date: 2009-11-04
End date: 2010-04-21
Other drugs received by patient: Fluorouracil; Levoleucovorin Calcium; Levoleucovorin Calcium; Vectibix; Fluorouracil; Fluorouracil; Fluorouracil
Possible Decadron side effects in 43 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-14
Patient: 43 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Confusional State, Drug Ineffective, Mouth Ulceration, Headache, Treatment Noncompliance, Nail Infection, Fatigue, Urinary Tract Disorder, Balance Disorder, Dyspepsia, Ingrowing Nail, Oedema, Food Craving, Pyuria, Drooling, Vomiting, Nausea, Hypoaesthesia, Neutrophilia, Aggression, Dysarthria, Breast Cancer Metastatic, Diarrhoea, Pollakiuria, Tooth Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Administration route: Oral
Decadron
Administration route: Oral
Start date: 2011-10-03
End date: 2011-10-12
Decadron
Administration route: Oral
Etoposide
Indication: Brain Cancer Metastatic
Start date: 2011-10-24
Decadron
Administration route: Oral
Indication: Metastases To Central Nervous System
Decadron
Administration route: Oral
Carboplatin
Indication: Breast Cancer Metastatic
Start date: 2011-10-24
Decadron Phosphate
Capecitabine
Dosage: 2 weeks out of every 3
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-02-22
End date: 2011-02-23
Capecitabine
Dosage: 2 weeks out of every 3
Administration route: Oral
Start date: 2011-03-14
Other drugs received by patient: Lapatinib
Possible Decadron side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08
Patient: female
Reactions: Skin Chapped, Abdominal Pain, Muscle Atrophy, Headache, Erythema, Malaise, Bronchitis Viral, Ingrowing Nail, Localised Infection, Cushingoid, Pain in Extremity, Bursitis, LIP Ulceration, Myopathy, Joint Swelling, Metastases To Central Nervous System, Rash Maculo-Papular, Purulent Discharge, Scab, Skin Toxicity, Death, Fatigue, Skin Ulcer, Chest Pain, Dizziness, Abdominal Distension, Oedema, Coordination Abnormal, Gastrooesophageal Reflux Disease, Rash Pustular, Vomiting, Gastrointestinal Toxicity, Muscular Weakness, Palmar-Plantar Erythrodysaesthesia Syndrome, DRY Skin, Rash, Diarrhoea, Gait Disturbance
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Capecitabine
Indication: Breast Cancer Metastatic
Start date: 2011-03-04
Decadron
Administration route: Oral
Indication: Metastases To Central Nervous System
Acyclovir
Lapatinib
Indication: Breast Cancer Metastatic
Start date: 2011-03-04
Other drugs received by patient: Herceptin; Zoledronate Disodium
Possible Decadron side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-03
Patient: female
Reactions: Confusional State, Drug Ineffective, Mouth Ulceration, Headache, Nail Infection, Treatment Noncompliance, Fatigue, Urinary Tract Disorder, Dyspepsia, Balance Disorder, Ingrowing Nail, Oedema, Food Craving, Pyuria, Drooling, Vomiting, Nausea, Hypoaesthesia, Neutrophilia, Aggression, Dysarthria, Breast Cancer Metastatic, Diarrhoea, Pollakiuria, Tooth Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Administration route: Oral
Carboplatin
Indication: Breast Cancer Metastatic
Start date: 2011-10-24
Lapatinib
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-02-22
End date: 2011-09-21
Decadron Phosphate
Etoposide
Indication: Brain Cancer Metastatic
Start date: 2011-10-24
Decadron
Administration route: Oral
Indication: Metastases To Central Nervous System
Decadron
Administration route: Oral
Decadron
Administration route: Oral
Decadron
Administration route: Oral
Start date: 2011-10-03
End date: 2011-10-12
Capecitabine
Dosage: 2 weeks out of every 3
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-02-22
End date: 2011-02-23
Capecitabine
Dosage: 2 weeks out of every 3
Administration route: Oral
Start date: 2011-03-14
Possible Decadron side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-06
Patient: 72 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Zygomycosis, Pneumonia, Diabetes Mellitus
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Other drugs received by patient: Insulin; Habekacin; Idamycin; Targocid; Ambisome; Vesanoid; Ciprofloxacin; Diflucan; Zosyn; Doripenem Monohydrate
Possible Decadron side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-13
Patient: 72 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Pneumonia, Zygomycosis, Diabetes Mellitus
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Other drugs received by patient: Idamycin; Insulin; Zosyn; Ambisome; Vesanoid; Targocid; Ciprofloxacin; Armodafinil; Habekacin; Doripenem Monohydrate
Possible Decadron side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-07
Patient: 72 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Pneumonia, Zygomycosis, Diabetes Mellitus
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Other drugs received by patient: Zosyn; Vesanoid; Targocid; Insulin; Idamycin; Ciprofloxacin; Armodafinil; Ambisome; Habekacin; Doripenem Monohydrate
Possible Decadron side effects in 76 year old male
Reported by a physician from Japan on 2012-03-06
Patient: 76 year old male, weighing 51.0 kg (112.2 pounds)
Reactions: Pulmonary Tuberculosis, Palmar-Plantar Erythrodysaesthesia Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Nexavar
Dosage: 400 mg, bid
Administration route: Oral
Indication: Hepatic Neoplasm Malignant
Start date: 2009-10-21
End date: 2009-11-01
Decadron
Dosage: daily dose 2 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-20
End date: 2011-08-08
Nexavar
Dosage: 400 mg (daily dose), , oral
Administration route: Oral
Start date: 2009-11-10
End date: 2011-08-08
Other drugs received by patient: Naproxen; Aspirin; Urso 250; Levofloxacin; Mucosolvan; Ticlopidine HCL; Lansoprazole; Lasix
Possible Decadron side effects in 45 year old female
Reported by a physician from United States on 2012-03-01
Patient: 45 year old female
Reactions: Encephalitis Herpes
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Possible Decadron side effects in 55 year old male
Reported by a physician from United States on 2012-03-01
Patient: 55 year old male
Reactions: Encephalitis Herpes
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decadron
Administration route: Oral
Indication: Malignant Melanoma
Decadron
Administration route: Oral
Indication: Metastases To Central Nervous System
Possible Decadron side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-28
Patient: 72 year old male, weighing 89.0 kg (195.8 pounds)
Reactions: Pneumonia, Zygomycosis, Diabetes Mellitus
Adverse event resulted in: death
Drug(s) suspected as cause:
Tretinoin
Dosage: 45mg/m2
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Idarubicin Hydrochloride
Indication: Acute Promyelocytic Leukaemia
Decadron
Administration route: Oral
Indication: Retinoic Acid Syndrome
Other drugs received by patient: Insulin
Possible Decadron side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-22
Patient: 72 year old male, weighing 89.0 kg (195.8 pounds)
Reactions: Pneumonia, Zygomycosis, Diabetes Mellitus
Adverse event resulted in: death
Drug(s) suspected as cause:
Tretinoin
Dosage: 45mg/m2
Administration route: Oral
Indication: Acute Promyelocytic Leukaemia
Decadron
Administration route: Oral
Indication: Retinoic Acid Syndrome
Idarubicin Hydrochloride
Indication: Acute Promyelocytic Leukaemia
Other drugs received by patient: Insulin
Page 1 Next >>
|